Launching a pharmaceutical marketing campaign takes months of planning, creative development and media strategy, followed by rigorous research and refinement. When the campaign finally goes live, marketers need confidence they are reaching the right high-value audience across a fragmented landscape, that targeting and measurement are accurate and that results reflect real-world impact. That confidence depends on one critical factor: syncing real patient signals to digital identifiers, both when building audiences and when measuring outcomes.
Healthcare marketers face a persistent challenge: connecting real-world health data to real-world patients in a PHI-based environment. Many data providers claim to offer high-quality audiences, but the value collapses if those audiences cannot be synced to digital identifiers for campaign measurement. And most audiences today are built on lookalike models rather than actual patient signals, so even a strong match rate points to the wrong people.
Agencies invest heavily in tagging campaigns, but without secure connectivity between media exposure and patient actions – such as prescription fills or treatment starts – ROI remains unclear. Fragmented data ecosystems and strict privacy regulations make this even harder. Marketers need a solution that bridges these gaps seamlessly – ensuring privacy while enabling accurate attribution and actionable insights.
As the advertising ecosystem continues to evolve, signal loss, platform restrictions, and channel fragmentation are reshaping how healthcare marketers maintain addressability. Durable identity solutions – built on consistent, privacy-safe de-identification – help preserve the connection between audience planning, activation, and measurement even as identifiers fluctuate or disappear.
For healthcare use cases, this is particularly critical: without stable identity linkage, cross-channel audiences lose fidelity, match rates drop, and outcome measurement becomes unreliable. Durable identity is now a foundational requirement for delivering scale responsibly in an increasingly complex environment. This is why activation products like HealthVerity Audiences are built on real patient signals synced to durable identifiers rather than lookalike modeling. When the underlying identity is stable and the source signal is real, audience quality and measurement do not degrade the way they do in the open web.
In healthcare marketing, PHI based solutions for data de-identification is a regulatory requirement. Tokenization technology has become a critical enabler of secure data connectivity, allowing marketers to link offline healthcare data with online identifiers while supporting privacy program requirements.
High match rates are essential for accurate audience targeting and reliable campaign measurement. When evaluating tokenization providers, marketers should ask:
Consistency, timing, and broad interoperability ensure that data can be connected responsibly while supporting meaningful measurement at scale. Watch our webinar to learn more about what healthcare marketers should ask when evaluating an audience solution.
Today’s audiences engage across many channels – video, mobile, display, and more privacy-centric environments. Effective healthcare marketing requires the ability to activate de-identified audiences where patients spend time, without losing fidelity or scale in the process.
When tokenization and identity framework are aligned, marketers can extend audience reach across channels more effectively and measure exposure in a consistent way. While channels differ in signals and identifiers, unified and privacy-safe audience resolution helps ensure campaigns perform as expected while maintaining compliance.
Symphony Health, a HealthVerity company and LiveRamp – the leader in data collaboration – bring confidence to healthcare marketers by leveraging advanced tokenization technology and identity resolution that enables high match rates across Symphony Health’s extensive healthcare data assets. All Symphony Health data is securely de-identified to meet industry standards through Synoma® tokenization, with LiveRamp helping to ensure consistency throughout the marketing process and removing any guesswork involved. By resolving data to LiveRamp’s durable, interoperable identifier RampID, we can provide advertisers with a secure identifier that maximizes audience fidelity across channels and devices.
Marketers can finally link campaign exposure to real-world outcomes with confidence.
The results speak for themselves: with LiveRamp, we are achieving match rates of ~70%, a level that confidently speaks to the campaign’s success. For marketers, this translates into:
Ultimately, this partnership and level of connectivity delivers unparalleled Audience Quality and Measurement, empowering pharmaceutical brands and agencies to make smarter, data-driven decisions.
Ultimately, this connectivity delivers the audience quality and measurement pharmaceutical brands and agencies need to make smarter decisions.
This is the foundation behind HealthVerity Audiences, the activation product powered by the combined HealthVerity and Symphony Health data ecosystem. Audiences are built from verified patient signals across claims, prescriptions and clinical data, then deployed via LiveRamp across digital, social, CTV and leading DSPs. Real signals from real patients, not lookalike models.
See how HealthVerity Audiences can support your next campaign.